On Wednesday, CSX Corporation (NYSE:CSX)’s shares declined -0.36% to $30.76.
Applications are now being accepted for the 2015 Grant Program for Transporting Healthy Food, presented in partnership by CSX and The Conservation Fund.
According to the United States Department of Agriculture more than 23 million Americans have limited or no access to fresh and healthy food. Many producers and retailers lack the resources and equipment needed to sustain food quality and safety as they sell, store, package and distribute fresh produce and other food to the surrounding communities they serve.
Now in its second year, the Grant Program for Transporting Healthy Food is designed to support and strengthen local transportation and distribution infrastructure for healthy food to communities in need. The program enhances delivery capabilities of producers and distributors and improves the availability of healthy food for nearby consumers. In 2014, the recipient organizations used the grants to purchase refrigeration and delivery trucks, acquire portable food chests and expand local food supply and capacity to provide nearly 118 million pounds of nutritious food to about six million people annually.
CSX Corporation, together with its auxiliaries, provides rail-based transportation services in the United States and Canada. It offers traditional rail services, and transports intermodal containers and trailers. The company transports crushed stone, sand and gravel, metal, phosphate, fertilizer, food, consumer, agricultural, automotive, paper, and chemical products; and coal, coke, and iron ore to electricity-generating power plants, steel manufacturers, and industrial plants, in addition to exports coal to deep-water port facilities. It also provides intermodal transportation services through a network of about 50 terminals transporting manufactured consumer goods in containers in the eastern United States, in addition to performs drayage services, counting pickup and delivery of intermodal shipments; and trucking dispatch services.
Palo Alto Netoperates Inc (NYSE:PANW)’s shares gained 2.65% to $190.42.
Palo Alto Networks Inc (PANW) shared research that uncovers a series of potentially state-sponsored cyberattacks targeting government and military organizations in countries throughout Southeast Asia.
Discovered by the Palo Alto Networks Unit 42 threat intelligence team and dubbed “Operation Lotus Blossom”, the attacks appear to be an attempt to gain inside information on the operation of nation-states throughout the region. The campaign dates as far back as three years and involves targets in Hong Kong, Taiwan, Vietnam, the Philippines and Indonesia.
Over 50 separate attacks have been identified in Operation Lotus Blossom. They all use a custom-built Trojan, named “Elise” to deliver highly targeted spear phishing emails and gain an initial foothold on targeted systems. Unit 42 believes the Elise malware was developed to specifically meet the unique needs of the operation, but also is being used in other non-related attacks by the adversary.
Palo Alto Networks, Inc. provides enterprise security platform to enterprises, service providers, and government entities worldwide. Its platform comprises Next-Generation Firewall that delivers application, user, and content visibility and control, in addition to protection against network-based cyber threats; and Threat Intelligence Cloud that offers central intelligence capabilities, in addition to automated delivery of preventative measures against cyber attacks.
At the end of Wednesday’s trade, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)‘s shares dipped -0.49% to $4.03.
Arena Pharmaceuticals, Inc. (ARNA) stated financial results for the second quarter ended June 30, 2015, and offered a corporate update.
Second Quarter and Recent Developments
Arena Research & Development
- Declared the initiation of patient screening in a Phase 2 proof-of-concept clinical trial of APD334, an oral Sphingosine 1-Phosphate Subtype 1 (S1P1) receptor modulator for autoimmune diseases, being studied in this trial for the treatment of ulcerative colitis.
- Arena and Roivant Sciences Ltd. reached a Development, Marketing and Supply Agreement for nelotanserin, Arena’s internally discovered inverse agonist of the serotonin 2A receptor.
- Declared results from a Phase 1 single-ascending dose clinical trial of APD371, a highly selective and potent cannabinoid 2 (CB2) receptor agonist in development as a potential treatment for pain.
Second Quarter 2015 Financial Results
- Revenues totaled $9.2 million, counting $4.3 million in net product sales of BELVIQ.
- Research and development expenses totaled $24.2 million.
- General and administrative expenses totaled $8.8 million.
- Net loss was $26.8 million, or $0.11 per share.
- At June 30, 2015, cash and cash equivalents totaled $216.7 million and about 242 million shares of common stock were outstanding.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight administration in adults. It is also developing a portfolio of programs in various therapeutic areas, counting cardiovascular, central nervous system, and metabolic diseases. Its products under development comprise Ralinepag, an agonist of the prostacyclin receptor intended for the treatment of vascular diseases, counting potentially pulmonary arterial hypertension that is in Phase II clinical trials.
AEGON N.V. (ADR) (NYSE:AEG), ended its Wednesday’s trading session with 0.65% gain, and closed at $7.76.
AEGON N.V. (ADR) (AEG) has accomplished a planned asset administration partnership with La Banque Postale. Under the terms of the agreement, Aegon has attained a 25% stake in La Banque Postale Asset Administration (LBPAM) for a consideration of EUR 112.5 million. LBPAM is the fifth largest asset manager in France, with about EUR 150 billion assets under administration.
The opportunity to create a planned partnership with La Banque Postale supports Aegon’s ambition to grow and diversify its customer base and to provide fee-based, capital-light products. It also represents a noteworthy step in implementing Aegon Asset Administration’s strategy to expand its services and solutions for third-party customers internationally.
The two companies will work together to further strengthen the development of LBPAM, which will offer a comprehensive range of products - counting international equity and multi-asset investment products. These will be distributed through La Banque Postale’s network of about 17,000 points of sale, online and by its institutional sales team.
Aegon N.V. provides life insurance, pensions, and asset administration services. The company operates through the Americas, the Netherlands, the United Kingdom, and New Markets. The company offers life and protection products, such as traditional and universal life, endowment, term, and whole life insurance products; and supplemental health, accidental death and dismemberment insurance, critical illness, cancer treatment, credit/disability, income protection, travel, and long-term care insurance.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
